BridgeBio Pharma Inc.
BBIO | NASDAQ
$75.86
+$0.91 (+1.21%)
Nov 2, 2026, 11:44 AM ET · Market open
Fiscal Quarter Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -60.5M | -155.89M | -166.56M | -190.26M | -182.74M | -183.76M | -169.61M | -267.39M | -164.25M | -73.46M | -36.16M | -170.33M | -179.49M | -160.7M | -142.73M | -140.57M | -140.19M | -2.56M | -201.33M | -152.28M | -161.02M | -96.35M | -171.08M |
Depreciation & Amortization | 1.07M | 1.05M | 1.19M | 1.44M | 1.4M | 1.32M | 1.28M | 1.37M | 1.54M | 1.57M | 1.6M | 1.59M | 1.64M | 1.64M | 1.63M | 1.66M | 1.65M | 1.58M | 1.88M | 1.53M | 265K | 3.49M | 566K |
Stock-Based Compensation | 39.86M | 44.07M | 33.24M | 34.64M | n/a | 37.24M | 25.88M | 30.13M | 27.16M | 21.45M | 17.06M | 37.03M | 22.6M | 27.18M | 21.91M | 21.79M | 17.36M | 28.29M | 24.12M | 19.77M | 16.04M | n/a | 33.58M |
Other Working Capital | -10.04M | 62.93M | -44.74M | 56.96M | 49.93M | -4.53M | -20M | 20.93M | 1.28M | -3.18M | 14.47M | 12.38M | 617K | 11.72M | -34.32M | -5.63M | -8.24M | 41.83M | -18.53M | 30.71M | -9.16M | 7.72M | -16.75M |
Other Non-Cash Items | 52.5M | 48.96M | 59.59M | 48.16M | 75.7M | 45.1M | 59.37M | 27.62M | -42.87M | -121.31M | 23.17M | -15.08M | 3.09M | 4.97M | 6.67M | 12.13M | -7.11M | -91.04M | 24.76M | -23.52M | 6.78M | 27.1M | 1.59M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -77.1M | -9.29M | -124.74M | 49.61M | -3.93M | 19.42M | -116.17M | 12.95M | -2.14M | 246.44M | -225.2M | 21.98M | 1.31M | 13.57M | -31.8M | 11.75M | -6.87M | 33.28M | -10.08M | 20.6M | 16.37M | -25.95M | -15.42M |
Operating Cash Flow | -44.17M | -71.1M | -197.28M | -56.42M | -109.57M | -80.68M | -199.24M | -195.33M | -180.57M | 74.7M | -219.54M | -124.82M | -145.23M | -113.35M | -144.32M | -93.24M | -135.16M | -30.45M | -160.64M | -133.9M | -121.56M | -91.71M | -150.77M |
Capital Expenditures | -290K | -443K | -69K | -4.53M | -470K | -5.09M | -1.6M | -3.24M | -1.73M | -2.45M | -1.49M | -435K | -431K | -428K | -12K | -801K | -759K | -3.9M | -859K | -2.54M | -41.46M | -2.29M | -1.96M |
Cash Acquisitions | n/a | n/a | n/a | 600K | n/a | n/a | n/a | n/a | n/a | -98K | n/a | n/a | -38.11M | n/a | -503K | n/a | -147.62M | n/a | n/a | n/a | n/a | -84.77M | n/a |
Purchase of Investments | n/a | -11.27M | -52.67M | -17.32M | -2.97M | -7.91M | n/a | n/a | n/a | -49.42M | -64.67M | -29.22M | -16.78M | -43.78M | -47.47M | -32.11M | -30.41M | -66.66M | -63.88M | -43.84M | -69.5M | -150.64M | -379.29M |
Sales Maturities Of Investments | 36.9M | 29.6M | 10M | 3M | 8M | n/a | n/a | n/a | 40M | 55M | 63.23M | 29.59M | 54.9M | 48.33M | 60.29M | 50.87M | 178.02M | 110.26M | 193.37M | 68.17M | 169.93M | 139.73M | 99.2M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 2.3M | -4.5M | n/a | -3.19M | -1.64M | -2.39M | 24.89M | n/a | 38.11M | n/a | n/a | n/a | 147.62M | 108.5M | 10M | n/a | -35M | 13.65M | n/a |
Investing Cash Flow | 36.61M | 17.89M | -42.74M | -13.75M | 4.46M | -13M | -1.6M | -3.24M | 38.23M | 3.04M | 22.75M | -66K | 37.68M | 4.12M | 12.3M | 17.97M | 146.86M | 149.7M | 138.62M | 21.8M | 58.97M | -84.31M | -282.05M |
Debt Repayment | -29.43M | n/a | 608.41M | -8.56M | -5.89M | 300M | 116M | 500M | n/a | -3.73M | -23.42M | n/a | n/a | n/a | n/a | n/a | n/a | -20.49M | n/a | 325.29M | n/a | 6.89M | 747.5M |
Common Stock Repurchased | -42.5M | -131.77M | -82.5M | n/a | n/a | -2M | -50.05M | -1.4M | -1.44M | -1.74M | -2.94M | -2.56M | -2.61M | -1.2M | -512K | 1.07M | -596K | -366K | -110K | -2.25M | -143.88M | -7.59M | -51.02M |
Dividend Paid | -2.69M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -5.09M | -22.22M | -4.07M | -7.43M | -3.03M | 4.04M | -5.62M | -24.67M | 2.17M | 241K | -9.35M | -1.51M | 3.44M | -1.06M | 7.75M | 396K | 2.04M | 56K | -50K | 2.35M | 8.43M | 80.32M | -148.57M |
Financial Cash Flow | 863.01M | -148.77M | 549.89M | -2.78M | -894K | 302.04M | 60.33M | 473.93M | 707K | -5.73M | 279.55M | -4.52M | 307.04M | -1.23M | 150.25M | 6.38M | 1.45M | -20.8M | -160K | 325.38M | -135.46M | 83.38M | 547.91M |
Net Cash Flow | 855.45M | -201.98M | 309.88M | -72.41M | -106.33M | 208.36M | -140.5M | 275.37M | -141.63M | 72.01M | 82.76M | -129.41M | 199.5M | -110.47M | 18.23M | -68.9M | 13.14M | 98.45M | -22.17M | 213.29M | -198.05M | -92.72M | 115.1M |
Free Cash Flow | -44.46M | -71.54M | -197.35M | -60.95M | -110.04M | -85.78M | -200.83M | -198.56M | -182.3M | 72.26M | -221.03M | -125.25M | -145.66M | -113.78M | -144.33M | -94.04M | -135.92M | -34.36M | -161.49M | -136.43M | -163.02M | -94M | -152.73M |
Adj. Free Cash Flow | -84.32M | -115.62M | -230.59M | -95.59M | -110.04M | -123.02M | -226.71M | -228.69M | -209.46M | 50.8M | -238.09M | -162.28M | -168.26M | -140.96M | -166.24M | -115.83M | -153.28M | -62.64M | -185.62M | -156.21M | -179.07M | -94M | -186.3M |
Maintenance CapEx | -290K | -443K | -69K | n/a | n/a | n/a | -1.6M | -1.81M | -1.73M | -2.26M | n/a | -435K | n/a | -428K | n/a | -801K | -759K | n/a | -132.43K | n/a | -41.46M | n/a | -1.61M |
Growth CapEx | n/a | n/a | n/a | -4.53M | -470K | -5.09M | n/a | -1.43M | n/a | -182.34K | -1.49M | n/a | -431K | n/a | -12K | n/a | n/a | -3.9M | -726.57K | -2.54M | n/a | -2.29M | -352.55K |
Owner Earnings | -44.46M | -71.54M | -197.35M | -56.42M | -109.57M | -80.68M | -200.83M | -197.13M | -182.3M | 72.44M | -219.54M | -125.25M | -145.23M | -113.78M | -144.32M | -94.04M | -135.92M | -30.45M | -160.77M | -133.9M | -163.02M | -91.71M | -152.37M |
Add to Watchlist
Select watchlists to add or remove BBIO